longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Guardian Pharmacy Services

GRDN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 42.93, within the reasonable range, cheaper than 73.18% of the time in the past 1 years, and the industry ranks 21/74, the industry Median --.

42.93xP/E
$44.67Stock price
$1.04Earnings per share
42.93xP/E
Stock price$44.67Earnings per share$1.04

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
47.94x
Typical range
38.57x–109.40x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BTSGUSBrightSpring Health Services
30.57x86.70%$11.19B
CRVLUSCorVel
32.23x--$3.72B
GRDNUSGuardian Pharmacy Services
42.93x56.67%$2.83B
PNTGUSPennant
42.62x35.12%$1.38B
INFUUSInfusystem
30.56x37.64%$261.11M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.